BlackRock
ROIV icon

BlackRock’s Roivant Sciences ROIV Stock Holding History

BlackRock’s Portfolio ROIV Stock Details ROIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.71B Buy
48,236,091
+3,981,831
+9% +$118M 0.03% 497
2026
Q1 		$1.23B Buy
44,254,260
+3,083,785
+7% +$79.2M 0.02% 593
2025
Q4 		$893M Buy
41,170,475
+1,445,596
+4% +$28.5M 0.02% 744
2025
Q3 		$601M Sell
39,724,879
-591,428
-1% -$7.32M 0.01% 966
2025
Q2 		$454M Sell
40,316,307
-1,343,181
-3% -$14.6M 0.01% 1117
2025
Q1 		$420M Sell
41,659,488
-498,043
-1% -$5.39M 0.01% 1145
2024
Q4 		$499M Buy
42,157,531
+195,472
+0.5% +$2.31M 0.01% 1093
2024
Q3 		$484M Buy
41,962,059
+6,591,789
+19% +$75M 0.01% 1094
2024
Q2 		$374M Sell
35,370,270
-817,249
-2% -$8.96M 0.01% 1199
2024
Q1 		$381M Buy
36,187,519
+15,381,918
+74% +$166M 0.01% 1216
2023
Q4 		$234M Buy
20,805,601
+3,082,064
+17% +$30M 0.01% 1554
2023
Q3 		$207M Buy
17,723,537
+5,350,664
+43% +$60.5M 0.01% 1516
2023
Q2 		$125M Buy
12,372,873
+6,170,264
+99% +$55.2M ﹤0.01% 1896
2023
Q1 		$45.8M Buy
6,202,609
+86,372
+1% +$711K ﹤0.01% 2506
2022
Q4 		$48.9M Buy
6,116,237
+800,258
+15% +$4.45M ﹤0.01% 2478
2022
Q3 		$17.1M Sell
5,315,979
-112,079
-2% -$434K ﹤0.01% 3120
2022
Q2 		$22.1M Buy
5,428,058
+1,383,639
+34% +$5.49M ﹤0.01% 3032
2022
Q1 		$20M Buy
4,044,419
+117,329
+3% +$774K ﹤0.01% 3174
2021
Q4 		$39.6M Buy
+3,927,090
New +$32.7M ﹤0.01% 2815

Other funds holding ROIV

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
QF
QVT Financial New York $1.7B AUM 173.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BlackRock's ROIV Position: Q2 2026 in Review

BlackRock increased its Roivant Sciences (ROIV) stake by 9% in Q2 2026, buying an estimated $118M and bringing the position to 48,236,091 shares worth $1.71B. The position accounts for 0.03% of the portfolio, ranked #497.

BlackRock first reported a position in ROIV in Q4 2021 and has held it in 19 quarters since. 497 funds tracked by Wall St. Rank hold ROIV as of Q2 2026.

  • BlackRock held 48,236,091 shares of Roivant Sciences worth $1.71B as of Q2 2026.
  • BlackRock bought 3,981,831 Roivant Sciences shares in Q2 2026, an estimated $118M.
  • Roivant Sciences made up 0.03% of BlackRock's portfolio in Q2 2026, its #497 holding.
  • BlackRock first reported a position in Roivant Sciences in Q4 2021 and has held it in 19 quarters since.
  • 497 funds tracked by Wall St. Rank held Roivant Sciences as of Q2 2026.

Based on BlackRock's 13F filing for Q2 2026, filed 7 Aug 2026.